These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17336256)

  • 1. Current Status and Future Directions in Graft-
    Tegla C; Choi J; Abdul-Hay M; Cirrone F; Cole K; Al-Homsi AS
    Clin Hematol Int; 2020 Mar; 2(1):5-12. PubMed ID: 34595437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.
    Das MK; Lunavat TR; Miletic H; Hossain JA
    Adv Exp Med Biol; 2021; 1326():139-157. PubMed ID: 33615422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TLR7 ligand R848 prevents mouse graft-
    Gaignage M; Marillier RG; Cochez PM; Dumoutier L; Uyttenhove C; Coutelier JP; Van Snick J
    Haematologica; 2019 Feb; 104(2):392-402. PubMed ID: 30213828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.
    Cornelissen JJ; Gratwohl A; Schlenk RF; Sierra J; Bornhäuser M; Juliusson G; Råcil Z; Rowe JM; Russell N; Mohty M; Löwenberg B; Socié G; Niederwieser D; Ossenkoppele GJ
    Nat Rev Clin Oncol; 2012 Oct; 9(10):579-90. PubMed ID: 22949046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.
    Stelljes M; Beelen DW; Braess J; Sauerland MC; Heinecke A; Berning B; Kolb HJ; Holler E; Schwerdtfeger R; Arnold R; Spiekermann K; Müller-Tidow C; Serve HL; Silling G; Hiddemann W; Berdel WE; Büchner T; Kienast J;
    Haematologica; 2011 Jul; 96(7):972-9. PubMed ID: 21459795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.
    Walter RB; Pagel JM; Gooley TA; Petersdorf EW; Sorror ML; Woolfrey AE; Hansen JA; Salter AI; Lansverk E; Stewart FM; O'Donnell PV; Appelbaum FR
    Leukemia; 2010 Jul; 24(7):1276-82. PubMed ID: 20485378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are matched unrelated donor transplants justified for AML in CR1?
    Anasetti C; Perkins J; Nieder ML; Field T
    Best Pract Res Clin Haematol; 2006; 19(2):321-8. PubMed ID: 16516129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
    Blum W; Bolwell BJ; Phillips G; Farag SS; Lin TS; Avalos BR; Penza SL; Marcucci G; Byrd JC; Kalaycio ME; Sobecks RM; Pohlman B; Brown S; Elder PJ; Copelan EA
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):61-7. PubMed ID: 16399569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission.
    Appelbaum FR
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):67-75. PubMed ID: 17336256
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.